07:00 , Oct 22, 2012 |  BC Week In Review  |  Clinical News

A/H5N1 Avian Influenza Vaccine: Phase I data

Top-line data from a pair of single-blind, placebo-controlled, dose-ranging, U.S. Phase I trials in a total of 666 healthy volunteers aged 18-49 showed that 2 intramuscular injections of Novavax's A/H5N1 Avian Influenza Vaccine given 21...
07:00 , Aug 6, 2012 |  BC Week In Review  |  Clinical News

A/H5N1 Avian Influenza Vaccine: Completed Phase I enrollment

Novavax completed enrollment in a pair of single-blind, placebo-controlled, dose-ranging, U.S. Phase I trials evaluating intramuscular A/H5N1Avian Influenza Vaccine given 21 days apart with or without an undisclosed adjuvant in about 333 healthy volunteers. The...
07:00 , May 14, 2012 |  BC Week In Review  |  Clinical News

A/H5N1 Avian Influenza Vaccine: Phase I started

Novavax began 2 single-blind, placebo-controlled, dose-ranging, U.S. Phase I trials to evaluate intramuscular A/H5N1 Avian Influenza Vaccine given 21 days apart with or without an undisclosed adjuvant in about 333 healthy volunteers. The trials are...